Comparison

Avelumab European Partner

Item no. TMO-T9903-100mg
Manufacturer TargetMol
CASRN 1537032-82-8
Amount 100 mg
Quantity options 100 mg 10 mg 1 mg 25 mg 50 mg 5 mg
Category
Type Molecules
Specific against other
ECLASS 10.1 32169090
ECLASS 11.0 32169090
UNSPSC 12000000
Shipping Condition Cool pack
Available
Manufacturer - Targets
PD-1/PD-L1
Storage Conditions
-20
Molecular Weight
143.8 kDa
Description
Avelumab, a fully human IgG1 anti-PD-L1 monoclonal antibody, exhibits potential antibody-dependent cell-mediated cytotoxicity.
Pathways
Cell Cycle/Checkpoint|||Apoptosis|||Immunology/Inflammation

Note: The presented information and documents (Manual, Product Datasheet, Safety Datasheet and Certificate of Analysis) correspond to our latest update and should serve for orientational purpose only. We do not guarantee the topicality. We would kindly ask you to make a request for specific requirements, if necessary.

All products are intended for research use only (RUO). Not for human, veterinary or therapeutic use.

Amount: 100 mg
Available: In stock
available

Compare

Add to wishlist

Get an offer

Request delivery time

Ask a technical question

Submit a bulk request

Questions about this Product?
 
Close